Human immunodeficiency virus type 1 envelope gp120 is cleaved after incubation with recombinant soluble CD4

A Werner1, J A Levy

  • 1Department of Medicine, School of Medicine, University of California, San Francisco 94143-0128.

Insights

Human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein gp120 is cleaved in purified virus preparations. This cleavage, occurring without added enzymes, is essential for HIV-1 cell entry and infection.

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • Human immunodeficiency virus type 1 (HIV-1) infects CD4+ cells via gp120-CD4 interaction.
  • Virus entry involves multiple steps, potentially including gp120 cleavage and fusion.
  • HIV-1 gp120 exhibits high variability but contains conserved motifs with cleavage sites.

Purpose of the Study:

  • To investigate gp120 cleavage in purified HIV-1 preparations.
  • To determine if gp120 cleavage occurs spontaneously or requires exogenous proteases.
  • To correlate gp120 cleavage with HIV-1 infectivity and neutralization sensitivity.

Main Methods:

  • Incubation of purified HIV-1 with soluble CD4.
  • Analysis of gp120 cleavage products using protein electrophoresis.
  • Assessment of HIV-1 strain-dependent proteolysis.
  • Correlation with recombinant soluble CD4 neutralization sensitivity.

Main Results:

  • gp120 in purified HIV-1 preparations undergoes cleavage upon incubation with soluble CD4.
  • Cleavage occurs without added proteases, yielding 50 and 70 kDa fragments, likely in the V3 loop.
  • The extent of gp120 proteolysis varies among HIV-1 strains.
  • Proteolysis extent correlates with sensitivity to neutralization by soluble CD4.

Conclusions:

  • gp120 cleavage is an intrinsic property of purified HIV-1 preparations.
  • This cleavage is likely essential for HIV-1 cell entry and infection.
  • The source of proteolytic activity within the virus preparations requires further investigation.